Mandate

Vinge advises Borgo in connection with the establishment of its MTN and covered bond programme and its inaugural issuance of MTNs

February 03, 2022 Banking and Finance

Vinge has advised Borgo AB (publ) (“Borgo”) in connection with the establishment of its SEK 50 billion MTN and covered bond programme (the “Programme”) and its inaugural issuance of SEK 1,75 billion MTNs (the “MTNs”).

The covered bonds issued under the Programme will be secured by underlying Swedish mortgage loans in accordance with the Swedish Covered Bonds Act. The MTNs carry an interest rate of STIBOR 3M + 0,90% and are intended to be listed on the corporate bond list of Nasdaq Stockholm. The Programme also caters for future issuances of green medium term notes, at the discretion of Borgo.

Borgo is a new independent mortgage lending company co-owned by ICA Banken, Ikano Bank, Söderberg & Partners and Ålandsbanken. Additional investors and Sparbanken Syd have committed to invest in Borgo. Borgo focuses on financing and offering mortgages to Swedish consumers.

Vinge’s team mainly consisted of Mikael Ståhl, Lionardo Ojeda, Axel Jansson and Felix Möller.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025